Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Review of Oxytocin and Arginine-Vasopressin Receptors and Their Modulation of Autism Spectrum Disorder
Ilaria Cataldo, Atiqah Azhari, Gianluca Esposito
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Towards complete and error-free genome assemblies of all vertebrate species
Arang Rhie, Shane McCarthy, Olivier Fédrigo, et al.
Nature (2021) Vol. 592, Iss. 7856, pp. 737-746
Open Access | Times Cited: 1954
The Neurochemistry of Autism
Rosa Marotta, Maria Cristina Risoleo, Giovanni Messina, et al.
Brain Sciences (2020) Vol. 10, Iss. 3, pp. 163-163
Open Access | Times Cited: 230
Towards complete and error-free genome assemblies of all vertebrate species
Arang Rhie, Shane McCarthy, Olivier Fédrigo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 128
Rescue of oxytocin response and social behaviour in a mouse model of autism
Hanna Hörnberg, Enrique Pérez‐Garci, Dietmar Schreiner, et al.
Nature (2020) Vol. 584, Iss. 7820, pp. 252-256
Open Access | Times Cited: 126
Social Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents
Richard E. Frye
CNS Drugs (2018) Vol. 32, Iss. 8, pp. 713-734
Open Access | Times Cited: 120
A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder
Federico Bolognani, Marta del Valle Rubido, Lisa Squassante, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 491
Closed Access | Times Cited: 100
The neuroscience of social feelings: mechanisms of adaptive social functioning
Paul J. Eslinger, Silke Anders, Tommaso Ballarini, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 128, pp. 592-620
Open Access | Times Cited: 76
Roles of the Oxytocin Receptor (OXTR) in Human Diseases
Karolina Pierzynowska, Lidia Gaffke, Magdalena Żabińska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3887-3887
Open Access | Times Cited: 30
Diencephalic and Neuropeptidergic Dysfunction in Zebrafish with Autism Risk Mutations
Mary E.S. Capps, Anna J. Moyer, Claire L. Conklin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 8
The Biology of Vasopressin
Samantha Sparapani, Cassandra Millet-Boureima, Joshua Oliver, et al.
Biomedicines (2021) Vol. 9, Iss. 1, pp. 89-89
Open Access | Times Cited: 44
The Synaptic and Circuit Functions of Vitamin D in Neurodevelopment Disorders
Xiaoshan Ye, Qionglin Zhou, Pengcheng Ren, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 1515-1530
Open Access | Times Cited: 19
Autism Spectrum Disorder: Signaling Pathways and Prospective Therapeutic Targets
Juliana Baranova, Guilherme Dragunas, Mayara C. S. Botellho, et al.
Cellular and Molecular Neurobiology (2020) Vol. 41, Iss. 4, pp. 619-649
Closed Access | Times Cited: 48
A randomized trial shows dose-frequency and genotype may determine the therapeutic efficacy of intranasal oxytocin
Juan Kou, Yingying Zhang, Feng Zhou, et al.
Psychological Medicine (2020) Vol. 52, Iss. 10, pp. 1959-1968
Open Access | Times Cited: 46
Dissociation of impulsivity and aggression in mice deficient for the ADHD risk gene Adgrl3: Evidence for dopamine transporter dysregulation
Niall Mortimer, Tatjana Ganster, Aet O’Leary, et al.
Neuropharmacology (2019) Vol. 156, pp. 107557-107557
Closed Access | Times Cited: 45
Genetic risk factors for autism-spectrum disorders: a systematic review based on systematic reviews and meta-analysis
Hongyuan Wei, Yunjiao Zhu, Tianli Wang, et al.
Journal of Neural Transmission (2021) Vol. 128, Iss. 6, pp. 717-734
Closed Access | Times Cited: 33
Towards the convergent therapeutic potential of G protein‐coupled receptors in autism spectrum disorders
Anil Annamneedi, Caroline Gora, Ana Dudas, et al.
British Journal of Pharmacology (2023)
Open Access | Times Cited: 14
Multiple Aspects of Inappropriate Action of Renin–Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases
Ewa Szczepańska‐Sadowska, Agnieszka Wsół, Agnieszka Cudnoch-Jędrzejewska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 908-908
Open Access | Times Cited: 19
The Role of Zinc in Developed Countries in Pediatric Patients: A 360-Degree View
Flavia Padoan, Elena Piccoli, Angelo Pietrobelli, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 718-718
Open Access | Times Cited: 4
Intranasal oxytocin administration ameliorates social behavioral deficits in a POGZWT/Q1038R mouse model of autism spectrum disorder
Kohei Kitagawa, Kensuke Matsumura, Masayuki Baba, et al.
Molecular Brain (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Recent Developments in Autism Genetic Research: A Scientometric Review from 2018 to 2022
Mengyu Lim, Alessandro Carollo, Dagmara Dimitriou, et al.
Genes (2022) Vol. 13, Iss. 9, pp. 1646-1646
Open Access | Times Cited: 17
Gene × Environment Interaction in Developmental Disorders: Where Do We Stand and What’s Next?
Gianluca Esposito, Atiqah Azhari, Jessica L. Borelli
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 29
Emerging pharmacological therapies in fragile X syndrome and autism
Hidenori Yamasue, Adi Aran, Elizabeth Berry‐Kravis
Current Opinion in Neurology (2019) Vol. 32, Iss. 4, pp. 635-640
Closed Access | Times Cited: 26
Autistic traits and cognitive profiles of treatment-resistant schizophrenia
Yusuke Nakata, Nobuhisa Kanahara, Atsushi Kimura, et al.
Schizophrenia Research Cognition (2020) Vol. 22, pp. 100186-100186
Open Access | Times Cited: 26
Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program
Suma Jacob, Evdokia Anagnostou, Eric Hollander, et al.
Molecular Autism (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Effects of intraperitoneal and intracerebroventricular injections of oxytocin on social and emotional behaviors in pubertal male mice
Toshiro Sakamoto, Shogo Sugimoto, Tomoko Uekita
Physiology & Behavior (2019) Vol. 212, pp. 112701-112701
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top